These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 20498653)

  • 1. Toll-like receptor 4 differentially regulates epidermal growth factor-related growth factors in response to intestinal mucosal injury.
    Hsu D; Fukata M; Hernandez YG; Sotolongo JP; Goo T; Maki J; Hayes LA; Ungaro RC; Chen A; Breglio KJ; Xu R; Abreu MT
    Lab Invest; 2010 Sep; 90(9):1295-305. PubMed ID: 20498653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of prostaglandin E2 (PGE 2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasia.
    Hernandez Y; Sotolongo J; Breglio K; Conduah D; Chen A; Xu R; Hsu D; Ungaro R; Hayes LA; Pastorini C; Abreu MT; Fukata M
    BMC Gastroenterol; 2010 Jul; 10():82. PubMed ID: 20637112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of the predictive markers amphiregulin and epiregulin mRNAs during long-term cetuximab treatment of KRAS wild-type tumor cells.
    Oliveras-Ferraros C; Massaguer Vall-Llovera A; Carrion Salip D; Vazquez-Martin A; Cufí S; Queralt B; Martin-Castillo B; Brunet J; de Llorens R; Menendez JA
    Invest New Drugs; 2012 Apr; 30(2):846-52. PubMed ID: 21161326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis.
    Ungaro R; Fukata M; Hsu D; Hernandez Y; Breglio K; Chen A; Xu R; Sotolongo J; Espana C; Zaias J; Elson G; Mayer L; Kosco-Vilbois M; Abreu MT
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1167-79. PubMed ID: 19359427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands.
    Brandl K; Sun L; Neppl C; Siggs OM; Le Gall SM; Tomisato W; Li X; Du X; Maennel DN; Blobel CP; Beutler B
    Proc Natl Acad Sci U S A; 2010 Nov; 107(46):19967-72. PubMed ID: 21041656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of epidermal growth factor receptor signaling by the prostaglandin E(2) receptor EP4 pathway during gastric tumorigenesis.
    Oshima H; Popivanova BK; Oguma K; Kong D; Ishikawa TO; Oshima M
    Cancer Sci; 2011 Apr; 102(4):713-9. PubMed ID: 21205091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor receptor mediates stress-induced expression of its ligands in rat gastric epithelial cells.
    Miyazaki Y; Hiraoka S; Tsutsui S; Kitamura S; Shinomura Y; Matsuzawa Y
    Gastroenterology; 2001 Jan; 120(1):108-16. PubMed ID: 11208719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development.
    Luetteke NC; Qiu TH; Fenton SE; Troyer KL; Riedel RF; Chang A; Lee DC
    Development; 1999 Jun; 126(12):2739-50. PubMed ID: 10331984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammary tumorigenesis induced by fibroblast growth factor receptor 1 requires activation of the epidermal growth factor receptor.
    Bade LK; Goldberg JE; Dehut HA; Hall MK; Schwertfeger KL
    J Cell Sci; 2011 Sep; 124(Pt 18):3106-17. PubMed ID: 21868365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-suppression of EGFR ligands amphiregulin and epiregulin and de-repression of FGFR3 signalling contribute to cetuximab resistance in wild-type KRAS tumour cells.
    Oliveras-Ferraros C; Cufí S; Queralt B; Vazquez-Martin A; Martin-Castillo B; de Llorens R; Bosch-Barrera J; Brunet J; Menendez JA
    Br J Cancer; 2012 Apr; 106(8):1406-14. PubMed ID: 22491422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the epidermal growth factor system in human middle ear cholesteatoma.
    Thorup MB; Munk M; Poulsen SS; Gaihede M; Nexo E; Sorensen BS; Ovesen T
    Acta Otolaryngol; 2014 Feb; 134(2):124-34. PubMed ID: 24256036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fulvestrant regulates epidermal growth factor (EGF) family ligands to activate EGF receptor (EGFR) signaling in breast cancer cells.
    Zhang X; Diaz MR; Yee D
    Breast Cancer Res Treat; 2013 Jun; 139(2):351-60. PubMed ID: 23686416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine.
    Fukata M; Chen A; Klepper A; Krishnareddy S; Vamadevan AS; Thomas LS; Xu R; Inoue H; Arditi M; Dannenberg AJ; Abreu MT
    Gastroenterology; 2006 Sep; 131(3):862-77. PubMed ID: 16952555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor ligands as new extracellular targets for the metastasis-promoting S100A4 protein.
    Klingelhöfer J; Møller HD; Sumer EU; Berg CH; Poulsen M; Kiryushko D; Soroka V; Ambartsumian N; Grigorian M; Lukanidin EM
    FEBS J; 2009 Oct; 276(20):5936-48. PubMed ID: 19740107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors.
    Fukata M; Chen A; Vamadevan AS; Cohen J; Breglio K; Krishnareddy S; Hsu D; Xu R; Harpaz N; Dannenberg AJ; Subbaramaiah K; Cooper HS; Itzkowitz SH; Abreu MT
    Gastroenterology; 2007 Dec; 133(6):1869-81. PubMed ID: 18054559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of EGFR ligands on endocytic sorting of the receptor.
    Roepstorff K; Grandal MV; Henriksen L; Knudsen SL; Lerdrup M; Grøvdal L; Willumsen BM; van Deurs B
    Traffic; 2009 Aug; 10(8):1115-27. PubMed ID: 19531065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast milk protects against the development of necrotizing enterocolitis through inhibition of Toll-like receptor 4 in the intestinal epithelium via activation of the epidermal growth factor receptor.
    Good M; Sodhi CP; Egan CE; Afrazi A; Jia H; Yamaguchi Y; Lu P; Branca MF; Ma C; Prindle T; Mielo S; Pompa A; Hodzic Z; Ozolek JA; Hackam DJ
    Mucosal Immunol; 2015 Sep; 8(5):1166-79. PubMed ID: 25899687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The DNA damaging agent VP16 induces the expression of a subset of ligands from the EGF system in bladder cancer cells, whereas none of the four EGF receptors are induced.
    Sørensen BS; Tørring N; Bor MV; Nexø E
    Mol Cell Biochem; 2004 May; 260(1-2):129-35. PubMed ID: 15228094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Luteinizing hormone signaling in preovulatory follicles involves early activation of the epidermal growth factor receptor pathway.
    Panigone S; Hsieh M; Fu M; Persani L; Conti M
    Mol Endocrinol; 2008 Apr; 22(4):924-36. PubMed ID: 18187604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autocrine and juxtacrine effects of amphiregulin on the proliferative, invasive, and migratory properties of normal and neoplastic human mammary epithelial cells.
    Willmarth NE; Ethier SP
    J Biol Chem; 2006 Dec; 281(49):37728-37. PubMed ID: 17035230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.